Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1998
08/19/1998EP0858327A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases
08/19/1998EP0858324A1 Process for aqueous granulation of clarithromycin
08/19/1998EP0858319A1 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration
08/19/1998EP0858313A2 Cosmetic and cosmeceutical compositions
08/19/1998EP0831842A4 Methods and compositions for inhibiting cytomegalovirus replication
08/19/1998EP0768882B1 Carbamazepine medicament with retarded active substance release
08/19/1998EP0767783B1 Substituted alkyldiamine derivatives and their use as tachykinin antagonists
08/19/1998EP0758896B1 Topical preparation containing aciclovir
08/19/1998EP0737186B1 Process for the preparation of leukotriene antagonists
08/19/1998EP0696291B1 Pyrido(1,2,3-de)quinoxaline derivatives, process for preparing the same and their use in medicaments
08/19/1998EP0688333B1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants
08/19/1998EP0667860B1 Aza spiro alkanes derivatives as therapeutic agents
08/19/1998EP0663825B1 USE OF MELATONIN in low oral doses TO INDUCE SLEEP
08/19/1998EP0660668B1 Iodine/resin disinfectant and a procedure for the preparation thereof
08/19/1998EP0643068B1 Erythromycin derivative
08/19/1998EP0549592B1 Stabilized retinoid-containing skin care compositions
08/19/1998EP0460058B1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
08/19/1998EP0454818B1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
08/19/1998CN1190974A Polysaccharide gel composition
08/19/1998CN1190972A Pyrmidine nucleoside derivatives
08/19/1998CN1190970A Resolution of 1-azabicyclo £2.2.2| octan-3-amine, 2-(diphenylmethyl)-N-££2-methoxy-5-(1-methylethyl) phenyl| methyl|
08/19/1998CN1190968A Piperazine derivatives and their use as 5-HT1A antagonists
08/19/1998CN1190967A Heterocyclylcarboxamide derivatives and their use as therapeutic agents
08/19/1998CN1190965A Diphenylmethylene piperidine derivatives
08/19/1998CN1190963A 2-amino-benzoxanones for the treatment of viral infections
08/19/1998CN1190958A N-oxides as antibacterial agents
08/19/1998CN1190957A Form III crystalline (R-(R*,R*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino) carbonyl)-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/19/1998CN1190956A Novel process for the production of amorphous £R-(R*,R*)|-2-(4-fluorophenyl)-'beta', 'delta'-dihydroxy-5-(1-methylethyl)-3-phenyl-4-£(phenylamino) carbonyl|-1H-pyrrole-1-heptanoic acid calcium ......
08/19/1998CN1190955A Crystalline £R-(R',R')|-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl|-1H-pyrole-1-heptanoic acid hemi calcium salt (atorvastatin)
08/19/1998CN1190896A Stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least, one basic amino acid residue and at least one acid amino acid residue
08/19/1998CN1190895A Use of ribavirin and interferon alpha for the treatment of hepatitis C
08/19/1998CN1190892A Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
08/19/1998CN1190891A Use of di-beta-D-glucopyranosylamine compounds for controlling inflammatory reactions, and method of systnesis
08/19/1998CN1190890A Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts
08/19/1998CN1190889A Zwitterionic forms of trovafloxacin
08/19/1998CN1190888A Methods and compositions for inhibiting 5 'alpha'=reductase activity
08/19/1998CN1190887A Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
08/19/1998CN1190650A Substituted phenyl acetanides, process for their preparation and intermediates thereof
08/19/1998CN1190596A External ointment for eczema and dermatitis
08/19/1998CN1190589A Complex ferrous sulfate tablet
08/19/1998CN1190582A Antipruritic ointment for dermatitis
08/19/1998CN1190581A Complex rifampin injection
08/19/1998CN1039536C 1,3 substituted condensed pyrazole compound, the application and preparation method
08/19/1998CN1039535C Synthesizing technology of Puyantong
08/19/1998CN1039522C Compounded painkilling and anti inflammatory ointment
08/19/1998CA2229966A1 Tasteless forms of basic drugs prepared by adsorption in situ
08/19/1998CA2223020A1 Human protein kinase hoacf72
08/18/1998US5795977 Water soluble adenosine kinase inhibitors
08/18/1998US5795916 Diclofenac sodium salt with water and fatty acid dialkylolamide and/or adduct with polyoxyethylene glycol
08/18/1998US5795915 Use of (x-aminomethyl-3,4-dichlorobenzyl) thioacetamide derivatives for inhibiting dopamine reutake and new compounds for this use
08/18/1998US5795913 Ophthalmic composition
08/18/1998US5795912 Ascorbyl tocopheryl phosphate
08/18/1998US5795911 Using tea catechin
08/18/1998US5795910 Method and compositions for inhibiting protein kinases
08/18/1998US5795909 DHA-pharmaceutical agent conjugates of taxanes
08/18/1998US5795908 Fkbp immunophilins for enzyme inhibitors
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/18/1998US5795904 Enhanced functional recovery of the heart by losartan treatment after an ischemic attach
08/18/1998US5795903 Anticonvulsants, antianxiety, schizophrenia, sleep disorders, brain disorders and alzheimer's or parkinson's disease
08/18/1998US5795902 3-substituted 2-oxindole-1 carboxamide pharmaceutical compositions
08/18/1998US5795900 Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
08/18/1998US5795899 Soluble salts of 4-amino-2-(4,4-dimethylimidazolidin-2-on-1-yl) pyrimidine-5-carboxylic acid N-methyl-N-(3-trifluoromethylphenyl)-amide, a process for the preparation thereof, the use thereof as pharmaceuticals and starting materials
08/18/1998US5795898 Method for treating diseases mediated by cellular proliferation in response to PDGF,EGF,FGF and VEGF
08/18/1998US5795897 Oxohexyl methylxanthine compounds
08/18/1998US5795895 Combination anorexiant drug therapy for obesity using phentermine and an SSRI drug
08/18/1998US5795893 Fibrinogen receptor antagonists
08/18/1998US5795892 Anticoagulants
08/18/1998US5795889 Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
08/18/1998US5795888 Analgesics, antiinflammatory agents, antidiabetic agents
08/18/1998US5795887 Method of inducing cholecystokinin agonist activity using 1,4- Benzodiazepine compounds
08/18/1998US5795886 Anticonvulsants
08/18/1998US5795883 Tocopherol or trolox group
08/18/1998US5795882 Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
08/18/1998US5795881 Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
08/18/1998US5795880 Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
08/18/1998US5795879 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
08/18/1998US5795877 Inhibitors of NAALADase enzyme activity
08/18/1998US5795876 Antiinflammatory agents
08/18/1998US5795875 Therapeutic methods of using O-desulfated heparin derivatives
08/18/1998US5795874 Bactericide against gramnegative, grampositive bacteria
08/18/1998US5795873 Method for treatment and prevention of deficiencies of vitamins B12, folic acid and B6
08/18/1998US5795872 DNA construct for immunization
08/18/1998US5795870 Steroid ring with amine group side chains
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795721 High affinity nucleic acid ligands of ICP4
08/18/1998US5795594 Salmeterol xinafoate with controlled particle size
08/18/1998US5795592 Calcium channel blocker
08/18/1998US5795579 Herpes simplex virus VP16 vaccines
08/18/1998US5795576 Chemical composition for aiding the absorption, binding and elimination of undigested fat
08/18/1998US5795575 Topical medicament which increases the number of capillaries in damaged skin
08/18/1998US5795567 Polyamines and method for preparation thereof
08/18/1998US5795564 Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
08/18/1998US5795563 Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2161768C 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
08/18/1998CA2115168C Defaunation method
08/18/1998CA2090340C Method of extracting sennosides a, b and a1
08/18/1998CA2089906C Naphthalene derivatives, processes for preparing the same, and synthetic intermediates therefor
08/18/1998CA2087104C Neuromuscular blocking agents
1 ... 6619 6620 6621 6622 6623 6624 6625 6626 6627 6628 6629 6630 6631 6632 6633 6634 6635 6636 6637 6638 6639 ... 7860